Similarly, higher CSF CHI3L1 levels have been correlated with the number of brain lesions on MRI in CIS patients [70,78], as well as with brain volume loss in CIS and RRMS patients [97]. The gene discussed is CHI3L1; the disease is in situ carcinoma.